助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   autologous transplant 的翻译结果: 查询用时:0.198秒
图标索引 在分类学科中查询
所有学科
儿科学
肿瘤学
更多类别查询

图标索引 历史查询
 

autologous transplant
相关语句
  “autologous transplant”译为未确定词的双语例句
     Methods Retrospective analysis for autologous transplant mainly with intravenous melphalan in 43 children with advanced malignant solid tumours was performed in our center.
     方法用回顾性分析的方法,对43例以静脉马法兰为主的预处理移植治疗的儿童高危恶性肿瘤临床资料进行分析。
短句来源
     Totally 45 autologous transplant were finished among these 43 patients because 2 patients received 2 consecutive transplants including 8 with bone marrow transplant and 37 with peripheral precursor transplant. The dosage of melphaelan was 140 mg/m2 in 8 cases, 180 mg/m2 in 10 cases and 210 mg/m2 in rest of 27 cases.
     因2例患儿连续进行2次移植,43例患儿共进行45例次移植,8例为骨髓移植、37例次为外周血造血干细胞移植,8例次患儿应用140mg/m2马法兰,10例应用180mg/m2马法兰,其余27例次应用210mg/m2马法兰。
短句来源
     Report on the autologous transplant mainly conditioned with intravenous melphalan in 43 chinese children with advanced malignant solid tumours
     以静脉马法兰为主的预处理自身移植治疗43例儿童高危恶性实体肿瘤
短句来源
     The canine kidney autologous transplant model was used to investigate the effect of ligustrazine with a certain concentration added to WMO1 solution on kidney preservation.
     通过犬自体肾移植模型研究了一定浓度的川芎嗪加入WMO-1号液对犬肾保存效果的影响。
短句来源
     High-dose chemotherapy accompanied by hematopoietic stem-cell support via autologous transplant is recommended up to the age of 65 -70 years.
     在65~70岁年龄组患者中推荐大剂量化疗联合经自体造血干细胞移植的治疗方案。
短句来源
  相似匹配句对
     The anatomical study of autologous bone tendon transplant
     自体骨—肌腱移植的解剖学研究
短句来源
     Recent advances of autologous stem cell transplant in malignant lymphoma
     恶性淋巴瘤自体造血干细胞移植后复发的研究进展
短句来源
     Discussion of The transplant of Law
     论法律价值移植
短句来源
     RANTES and transplant rejection
     RANTES与移植排斥
短句来源
     AUTOLOGOUS MIXED LYmPHOCYTE REACTION
     自身混合淋巴细胞反应
短句来源
查询“autologous transplant”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法,我们为您准备了出自英文原文的大量英语例句,供您参考。
  autologous transplant
Although autologous transplantation has improved outcomes for younger patients, the use of a second autologous transplant in the relapsed setting has less benefit.
      
Therapeutic options for patients with hodgkin's disease and non-hodgkin's lymphoma who relapse after autologous transplant
      
Allogeneic transplant patients reported higher pain intensity than did autologous transplant patients.
      
One case was positive at the beginning of CR and became negative after autologous transplant.
      
Peripheral blood stem cell CD34+ autologous transplant in relapsed follicular lymphoma
      
更多          


The canine kidney autologous transplant model was used to investigate the effect of ligustrazine with a certain concentration added to WMO1 solution on kidney preservation. The results showed that the canine autologously transplanted kidneys were difficult to survive with 72h preservation of WMO-1 alone and WMO-1 plus ligustrazine. The mean serum creatine level after operation in 48 h ligustrazine preservation group was lower than in 48 h WMO-1 preservation group, and the recovery of serum creatine...

The canine kidney autologous transplant model was used to investigate the effect of ligustrazine with a certain concentration added to WMO1 solution on kidney preservation. The results showed that the canine autologously transplanted kidneys were difficult to survive with 72h preservation of WMO-1 alone and WMO-1 plus ligustrazine. The mean serum creatine level after operation in 48 h ligustrazine preservation group was lower than in 48 h WMO-1 preservation group, and the recovery of serum creatine level in the former group was earlier than in the latter group (P<0.05). These results suggested that the ligustrazine concentration used could not prolong the preservation time of WMO-1 solution to kidney, but could be of benefit to the recovery of renal function in the early stage. 

通过犬自体肾移植模型研究了一定浓度的川芎嗪加入WMO-1号液对犬肾保存效果的影响。结果表明,单纯WMO-1号液保存72小时和加川芎嗪保存72小时的肾行自体移植均难存活;加川芎嗪保存48小时组术后血肌酐的平均值低于单纯WMO-1号液保存48小时组,且血肌酐恢复正常的时间也较单纯WMO-1号液组早(P<0.05),说明该实验浓度的川芎嗪不能延长肾保存时间,但有利于移植肾功能的早期恢复。

Objective CD34 + is an immunophenotype of hematopoietic stem cells/progenitors. CD34 + cells selection in vitro may deplete T cells 4 5 logs and tumor cells 3 4 logs. It will benefit to mismatched related donor allo transplantation and autologous transplantation of tumor diseases. Methods 19 patients aged 29 (5~52) years were treated by allo ( n =5) or auto PB CD34 + cells transplantation ( n =14). Grafts from fifteen patients with various disorders (3 lymphomas, 6 multiple myelomas, 2 SLE,...

Objective CD34 + is an immunophenotype of hematopoietic stem cells/progenitors. CD34 + cells selection in vitro may deplete T cells 4 5 logs and tumor cells 3 4 logs. It will benefit to mismatched related donor allo transplantation and autologous transplantation of tumor diseases. Methods 19 patients aged 29 (5~52) years were treated by allo ( n =5) or auto PB CD34 + cells transplantation ( n =14). Grafts from fifteen patients with various disorders (3 lymphomas, 6 multiple myelomas, 2 SLE, 1 Sjogren's syndrome, 2 breast cancer and 1 medulloblastoma) and five haploidentical donors for leukemia patients (1 ALL CR2, 2 AML rel, 1 CML CP and 1 MDS RAEB) were isolated using magnetic activated cell sorting (CliniMACS, Milteny Biotech, Germany). Results After separation, purity of CD34 + cells was >97 %. Depletion of CD34 negative cells was extensive: CD3 + 2.6~4.6 logs, CD4 + >5 logs, CD8 + 4.6 > 5 logs, and CD19 + 1.2~3.1 logs. 19 patients who received selected CD34 + cells transplantation (CD34 +CT) were followed up for 11(1~20) months. Overall survival(OS) was 13/19 (68.4%) cases. 1/5 patients with haploidentical transplant had disease free survival for 19 months. 12/14(85.7%) auto CD34 +CT achieved overall survival(OS). Conclusion Selected CD34 + cells transplantation significantly decreases the incidence of >Ⅱ GVHD and depletes tumor cell contamination. This approach may be useful to haploidentical or unrelated donor transplantation. It also benefits autologous transplant in various tumor disorders.

目的 观察富集CD34+的造血干 /祖细胞做肿瘤患者同种异基因造血干细胞移植 (Allo HSCT)和自体移植的临床疗效。观察输注纯化CD34+细胞患者的预后情况。方法 采用磁分选临床型细胞富集仪将表面包被有CD34单抗的磁性微球体系与细胞共同培养 ,特异性结合CD34+细胞。在磁场作用下分别收集CD34+和CD34-组分。完成 2 0例患者CD34+细胞体外纯化富集。其中HLA半相合移植 5例 ,自体移植 15例。结果 纯化后CD34+细胞纯度达 97%以上 ,移植CD34+细胞中位数 5 .72 (0 .15~ 12 .0 )× 10 6,CD34+细胞中位数 3.73(2 .6~ 6 .8)× 10 4 ;CD34-细胞 (CD3、CD4、CD8、CD19)对数去除率 (Log,下同 )为 1.99~ 5 .0。 19例患者移植后随访 11个月 (中位数 ,1~ 2 0 ) ,总体生存13/ 19(例 )。本院 11例中 ,总体生存为 8/ 11(例 ) ,其中HLA半相合 1/ 3(例 ) ,自体移植 7/ 8(例 )。移植后造血重建迅速 ,随访 18个月以上无病生存者 3例中 1例为同种异基因HLA...

目的 观察富集CD34+的造血干 /祖细胞做肿瘤患者同种异基因造血干细胞移植 (Allo HSCT)和自体移植的临床疗效。观察输注纯化CD34+细胞患者的预后情况。方法 采用磁分选临床型细胞富集仪将表面包被有CD34单抗的磁性微球体系与细胞共同培养 ,特异性结合CD34+细胞。在磁场作用下分别收集CD34+和CD34-组分。完成 2 0例患者CD34+细胞体外纯化富集。其中HLA半相合移植 5例 ,自体移植 15例。结果 纯化后CD34+细胞纯度达 97%以上 ,移植CD34+细胞中位数 5 .72 (0 .15~ 12 .0 )× 10 6,CD34+细胞中位数 3.73(2 .6~ 6 .8)× 10 4 ;CD34-细胞 (CD3、CD4、CD8、CD19)对数去除率 (Log,下同 )为 1.99~ 5 .0。 19例患者移植后随访 11个月 (中位数 ,1~ 2 0 ) ,总体生存13/ 19(例 )。本院 11例中 ,总体生存为 8/ 11(例 ) ,其中HLA半相合 1/ 3(例 ) ,自体移植 7/ 8(例 )。移植后造血重建迅速 ,随访 18个月以上无病生存者 3例中 1例为同种异基因HLA半相合亲属移植 ,2例为肿瘤自体移植。 1例父子间HLA半相合移植 ,白细胞恢复 >1× 10 9/L ,血小板 >2 0× 10 9/L(均为移植后第 13天 )。仅有短暂的I度移植物抗宿主疾病。 2例自体移植病例白细胞恢复 >1× 10 9/L(8~ 2 6d) ,血小板恢复 >2 0× 10 9/L(2 2~ 35d)。结论 

Therapeutic cloning has been envisaged to create cells, tissues or organs for human autologous transplant therapy. Using the technique of nuclear transfer, the patient somatic cell is transferred into a matured and enucleated oocyte. The somatic nuclei from the patient are reprogrammed and develop into the balstocyst embryos, from which scientists derive the embryonic stem (ES) cell and establish the ES cell line identical to the patient in genetics. ES cell have the potentiality to differentiate into...

Therapeutic cloning has been envisaged to create cells, tissues or organs for human autologous transplant therapy. Using the technique of nuclear transfer, the patient somatic cell is transferred into a matured and enucleated oocyte. The somatic nuclei from the patient are reprogrammed and develop into the balstocyst embryos, from which scientists derive the embryonic stem (ES) cell and establish the ES cell line identical to the patient in genetics. ES cell have the potentiality to differentiate into various somatic cell types. Upon further inducttion, the ES cells derived from patient give rise to the cell type to meet the needs of patient. Then the ES cells are transplanted into patient to replace or repair the patients' cells, tissues or organs, which have been lost their function. Through such way, the normal physiological function of the patient will be recovered and the disease will be healed. Therefore, therapeutic cloning not only avoids the problem of immune rejection between the graft and recipient, but also overcome the problem of the source of grafts.

治疗性克隆是利用核移植技术将病人的体细胞核移植到去核的卵母细胞中 ,使其重编程并发育成囊胚 ,然后再用胚胎干细胞分离技术从克隆囊胚的ICM分离出多能胚胎干细胞 (ES)。这种干细胞在遗传学上和病人完全一致 ,再定向诱导其分化成病人所需要的体细胞进行移植 ,以取代和修复患者已丧失功能的细胞、组织或器官 ,而达到完全治愈。治疗性克隆不仅解决移植物与受者间的免疫排斥反应问题 ,而且可以解决移植物的来源问题

 
<< 更多相关文摘    
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关autologous transplant的内容
在知识搜索中查有关autologous transplant的内容
在数字搜索中查有关autologous transplant的内容
在概念知识元中查有关autologous transplant的内容
在学术趋势中查有关autologous transplant的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社